IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.6967
+0.0186 (2.74%)
At close: Dec 5, 2025, 4:00 PM EST
0.7138
+0.0171 (2.45%)
After-hours: Dec 5, 2025, 7:59 PM EST
IO Biotech Market Cap
IO Biotech has a market cap or net worth of $50.13 million as of December 5, 2025. Its market cap has decreased by -12.99% in one year.
Market Cap
50.13M
Enterprise Value
37.58M
1-Year Change
-12.99%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since the IPO on November 5, 2021, IO Biotech's market cap has decreased from $369.28M to $50.13M, a decrease of -86.43%. That is a compound annual growth rate of -38.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 48.79M | -19.50% |
| Dec 31, 2024 | 60.61M | -51.06% |
| Dec 29, 2023 | 123.86M | 86.88% |
| Dec 30, 2022 | 66.28M | -64.06% |
| Dec 31, 2021 | 184.42M | -50.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |